B cell acute lymphoblastic leukemia following mild COVID-19 in an
11-year-old boy
Abstract
Coronavirus disease-2019 (COVID-19) has infected millions of people with
high lethality in the world, but little is known whether severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has impacts on
triggering pediatric acute lymphoblastic leukemia (ALL). We present a
case of a child with atypical clinical manifestation who developed
B-cell acute lymphoblastic leukemia following a mild symptomatic
COVID-19 infection. This case underlines the risks of potential
oncogenic effects with the history of this viral infection and a state
of immunosuppression.